NobleCon21 Presentation Replays

12/8/2025

Business

0 min read

Watch all of the presentation and Q&A sessions from NobleCon21 – Noble Capital Markets’ 21 annual emerging growth equity conference. Replays are available to all registered Channelchek members. Registration is free and easy.

Access to Exclusive Content. FREE for Registered Users Only.

Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.

‌

The site "channelcheck" is opened on the phone

Welcome to the Channelchek Investor Community

We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.

Don't have an account? Join

Forgot password

By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.

Release – Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027

Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that the U.S. Food and Drug Administration (FDA)...

6 min read

‌

Release – BODi Launches INSANITY “Liquid Shock” Energy Drink Designed For Sharper Focus, Improved Reaction Time, Physical Performance and a Huge Jolt of Energy

10/21/2026

Health

Release – BODi Launches INSANITY “Liquid Shock” Energy Drink Designed For Sharper Focus, Improved Reaction Time, Physical Performance and a Huge Jolt of Energy

BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health inside and out, today announced the launch of...

4 min read

‌

Release – Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia

10/21/2026

Health

Release – Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...

5 min read

‌

Release – SKYX and Its Subsidiary Deako Announce They Will Supply Over 80,000 Units of Their Smart Home Technologies to Over 1,000 Homes of Prominent Home Builder Maronda Homes, as the Company Continues to Grow Its Market Penetration

10/21/2026

Manufacturing

Release – SKYX and Its Subsidiary Deako Announce They Will Supply Over 80,000 Units of Their Smart Home Technologies to Over 1,000 Homes of Prominent Home Builder Maronda Homes, as the Company Continues to Grow Its Market Penetration

SKYX Platforms Corp. (NASDAQ: SKYX) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 120 patents and pending applications globally and over 60 lighting and home...

5 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

NewsMorning ResearchVideos

By clicking submit you are agreeing to the Terms of Use and Privacy Policy